Target intelligence / Profile preview

PNRC1 divergent transcript (PNRC1-DT)

Target
PNRC1-DT
Molecular classification
Other (Long non-coding RNA)
01

Overview

PNRC1 divergent transcript (PNRC1-DT) is a long non-coding RNA (lncRNA) gene located at the PNRC1 locus, distinct from the protein-coding PNRC1 gene[4][6]. Unlike PNRC1, which encodes a nuclear receptor coactivator implicated in tumor suppression and rRNA processing regulation[1][3][6], PNRC1-DT is an RNA molecule believed to arise from divergent transcription at the locus and does not encode a functional protein. Its biological function, disease roles, and therapeutic relevance remain undetermined. There is frequent confusion between PNRC1-DT (the non-coding transcript) and PNRC1 (the nuclear receptor coactivator protein), but they are scientifically and functionally distinct. If you require information about the protein-coding PNRC1, which acts as a nuclear receptor coactivator and has emerging roles in cancer biology, please clarify, as that is a true molecular target with established literature[1][3][6]. For PNRC1-DT, data is limited and it is not considered a drug target.

Other names
PNRC1 Divergent TranscriptPNRC1-DT
02

Biological functions

Other (Potential gene regulation, possibly involved in chromatin organization or transcriptional modulation, but no definitive function established)
03

Disease associations

Other (No clear disease associations or target roles currently established)

Beyond the preview

Go deeper on PNRC1 divergent transcript (PNRC1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PNRC1 divergent transcript (PNRC1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call